Internship
Engineering Intern
Confirmed live in the last 24 hours
Selux Diagnostics
51-200 employees
Provides rapid antibiotic susceptibility testing
Boston, MA, USA
- GPA >3.2 pursuing an Engineering degree with an interest in integration of biochemical/electromechanical/software systems and medical device product development.
- The ability to work safely and comfortably in a wet lab environment with chemicals and microorganisms. Appropriate training and PPE will be provided.
- Be an independent thinker and problem-solver who is enthusiastic and collaborative.
- Excellent written and oral communication skills and proven ability to work well in a team environment.
- Diligent, organized, and detail-oriented. Must be able to follow detailed instructions carefully and accurately and carefully document test results.
- Vaccination for COVID-19 is a requirement of employment.
- Implement new designs and features into existing robotics to improve reliability, speed, user interface, and lifetime.
- Test new software and features provided by contract engineering design firms.
- Troubleshoot equipment and software problems and perform root-cause failure analysis when anomalous behavior or test results occur.
- Perform statistical analysis of test results and data and present these results to a technical team of scientists and engineers.
- Support design documentation (CAD, drawings, specifications) on various components of the diagnostic systems for a regulated Design History File.
Selux Diagnostics focuses on antibiotic susceptibility testing (AST) to address the growing issue of antimicrobial resistance (AMR). The company provides healthcare providers, such as hospitals, with rapid and accurate testing results that determine how bacteria respond to various antibiotics. This technology allows for simultaneous testing against all relevant antibiotics, which is a notable advancement in a field that has seen little progress in recent years. By delivering faster diagnostic results and comprehensive susceptibility profiles, Selux helps healthcare professionals prescribe the most effective antibiotics, reducing the risk of incorrect or unnecessary prescriptions. The goal of Selux Diagnostics is to preserve the effectiveness of antibiotics for future generations and combat the global health crisis posed by AMR.
Company Stage
N/A
Total Funding
$175M
Headquarters
Boston, Massachusetts
Founded
2014
6 month growth
↑ 8%1 year growth
↑ 6%2 year growth
↑ 32%
Simplify's Take
What believers are saying
- Recent FDA clearances and substantial funding rounds, including a $48 million investment, position Selux for aggressive expansion and product development.
- The addition of industry veterans to the board and advisory roles enhances the company's strategic direction and credibility in the healthcare sector.
- Selux's rapid and accurate AST technology can significantly improve patient outcomes, reduce hospital stays, and combat the global antibiotic resistance crisis, making it a highly impactful place to work.
What critics are saying
- The high costs associated with developing and commercializing advanced diagnostic technologies could strain financial resources.
- The competitive landscape in healthcare diagnostics is intense, with larger, more established companies potentially overshadowing Selux's innovations.
What makes Selux Diagnostics unique
- Selux Diagnostics offers the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies, setting it apart from competitors.
- Their Next Generation Phenotyping (NGP) platform significantly increases the speed and accuracy of targeted antibiotic therapies, a breakthrough in a field that has seen little innovation in decades.
- Selux's comprehensive testing against all commercially relevant antibiotics at once is a unique feature that addresses a critical need in combating antimicrobial resistance.
Help us improve and share your feedback! Did you find this helpful?